PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26550961-9	2016	Moreover, the expression of mRNAs and proteins of CCL3 and its receptor CCR5 in DRG were dramatically increased after remifentanil infusion as compared with the normal saline group.	Remifentanil	118-130	C-C motif chemokine ligand 3	Rattus norvegicus	50-54	
26550961-12	2016	CONCLUSIONS: The results highlighted the fact that CCL3 and its receptor CCR5 in DRG might contribute to remifentanil-induced hyperalgesia.	Remifentanil	105-117	C-C motif chemokine ligand 3	Rattus norvegicus	51-55	
26550961-0	2016	Involvement of CCL3/CCR5 Signaling in Dorsal Root Ganglion in Remifentanil-induced Hyperalgesia in Rats.	Remifentanil	62-74	C-C motif chemokine ligand 3	Rattus norvegicus	15-19	
26550961-3	2016	In this paper we explored whether CCL3 and CCR5, the mainly receptor of CCL3, play a role in the remifentanil-induced hyperalgesia in DRG by using a rat model with remifentanil administration.	Remifentanil	97-109	C-C motif chemokine ligand 3	Rattus norvegicus	34-38	
26550961-3	2016	In this paper we explored whether CCL3 and CCR5, the mainly receptor of CCL3, play a role in the remifentanil-induced hyperalgesia in DRG by using a rat model with remifentanil administration.	Remifentanil	97-109	C-C motif chemokine ligand 3	Rattus norvegicus	72-76	
26550961-3	2016	In this paper we explored whether CCL3 and CCR5, the mainly receptor of CCL3, play a role in the remifentanil-induced hyperalgesia in DRG by using a rat model with remifentanil administration.	Remifentanil	164-176	C-C motif chemokine ligand 3	Rattus norvegicus	34-38	
26550961-5	2016	Real-time polymerase chain reaction and Western blot analysis were used to evaluate time course of CCL3 and CCR5 expression in DRG after remifentanil infusion.	Remifentanil	137-149	C-C motif chemokine ligand 3	Rattus norvegicus	99-103